Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood and tissue samples sought to refine cancer DNA tests

NCT ID NCT07318051

Recruiting now Knowledge-focused Sponsor: Natera, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects blood and leftover tissue samples from 9,600 people with various cancers, including breast, lung, and pancreatic cancer. Researchers will use these samples to improve tests that look for cancer DNA in the blood. The goal is to better detect if cancer returns or how well treatment is working.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better blood tests to detect cancer recurrence or monitor treatment response across many cancer types.

What could go wrong

This is an observational sample collection study, not a treatment trial. It does not test a therapy, so it cannot directly improve patient outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm endometrial cancer gastroesophageal cancer head and neck cancer Head and Neck Neoplasms infiltrating bladder urothelial carcinoma liver cancer Liver Neoplasms lung cancer lung neoplasm malignant pancreatic neoplasm melanoma ovarian cancer pancreatic neoplasm prostate cancer rectal cancer rectal neoplasm uterine cancer uterine corpus cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER GASTROESOPHAGEAL CANCER HEAD AND NECK CANCER HEPATIC/LIVER CANCER LIVER CANCER LUNG CANCER MELANOMA MUSCLE-INVASIVE BLADDER CANCER OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RECTAL CANCER UTERINE CANCER UTERINE/ENDOMETRIAL CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Natera, Inc.

    RECRUITING

    Austin, Texas, 78753, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••